Skip to main content
67°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pliant Therapeutics Inc
(NQ:
PLRX
)
12.63
-0.10 (-0.79%)
Streaming Delayed Price
Updated: 9:38 AM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pliant Therapeutics Inc
< Previous
1
2
3
4
Next >
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
April 13, 2023
Via
Benzinga
Expert Ratings for Pliant Therapeutics
April 13, 2023
Via
Benzinga
7 Biotech Stocks to Buy for 100% Returns
April 09, 2023
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
Via
InvestorPlace
The Latest Analyst Ratings for Pliant Therapeutics
March 28, 2023
Via
Benzinga
9 Analysts Have This to Say About Pliant Therapeutics
March 10, 2023
Via
Benzinga
Why Pliant Therapeutics Stock Is Skyrocketing This Week
January 26, 2023
The company's experimental idiopathic pulmonary fibrosis drug is showing a lot of promise.
Via
The Motley Fool
Expert Ratings for Pliant Therapeutics
January 23, 2023
Via
Benzinga
An Unexpected Feat Just Sent Pliant Therapeutics Soaring More Than 50%
January 23, 2023
The company has a potentially best-in-class approach to a lung condition.
Via
Investor's Business Daily
Novartis Takes Down $80M NASH Pact With Pliant Therapeutics
February 24, 2023
Via
Benzinga
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher
January 23, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday. The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. The...
Via
Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its...
Via
Benzinga
Dow, Nasdaq Boasting Triple-Digit Midday Lead
January 23, 2023
Investors seem intent on leaving last week's losses behind, as earnings season heats up.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
Via
Benzinga
Dow Jumps Over 300 Points; Crude Oil Up 1%
January 23, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday. The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500...
Via
Benzinga
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
January 23, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday.
Via
Benzinga
Why Is Xylem (XYL) Stock Down 9% Today
January 23, 2023
Xylem (XYL) stock is slipping on Monday after the company revealed plans to acquire Evoqua (AQUA) in a $7.5 billion deal.
Via
InvestorPlace
Why Is Ryvyl (RVYL) Stock Is On the Move Today?
January 23, 2023
Ryvyl (RVYL) stock is on the move Monday after saying its prior financial data can no longer be relied on and revealing an investigation.
Via
InvestorPlace
Benzinga's Talk of the Town: Top Social Trending Stories You Need To Know
January 23, 2023
What's trending on Social Media today:
Via
Benzinga
Why Is Pliant Therapeutics (PLRX) Stock Up 62% Today?
January 23, 2023
Pliant Therapeutics (PLRX) stock is taking off on Monday after releasing positive Phase 2a clinical trial data for bexotegrast.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 23, 2023
Via
Benzinga
Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
January 23, 2023
Gainers Jeffs' Brands Ltd (NASDAQ: JFBR) rose 76.5% to $2.70 in pre-market trading after jumping 19% on Friday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 23, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers traders will want to watch for Monday!
Via
InvestorPlace
Pliant Therapeutics Stock Surges After Positive Data From Lead Program In Scarred Lung Disorder
January 23, 2023
Pliant Therapeutics Inc (NASDAQ: PLRX) has announced 12-week interim data from the 320 mg dose group of INTEGRIS-IPF Phase 2a clinical trial of bexotegrast (PLN-74809) in patients with idiopathic...
Via
Benzinga
Salesforce, Tesla And Other Big Stocks Moving Higher In Monday's Pre-Market Session
January 23, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 02, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
3 Soaring Biotech Stocks That Could Climb Much Higher
October 20, 2022
These drugmakers have bucked the overall market's downward trend this year and expectations are still high.
Via
The Motley Fool
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 2022
Gainers
Via
Benzinga
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
September 21, 2022
Gainers
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.